These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24786148)

  • 1. The G551D CFTR chloride channel spurs the development of personalized medicine.
    Fischer H
    J Physiol; 2014 May; 592(9):1907-8. PubMed ID: 24786148
    [No Abstract]   [Full Text] [Related]  

  • 2. Revertant mutants modify, but do not rescue, the gating defect of the cystic fibrosis mutant G551D-CFTR.
    Xu Z; Pissarra LS; Farinha CM; Liu J; Cai Z; Thibodeau PH; Amaral MD; Sheppard DN
    J Physiol; 2014 May; 592(9):1931-47. PubMed ID: 24591578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G551D and G1349D, two CF-associated mutations in the signature sequences of CFTR, exhibit distinct gating defects.
    Bompadre SG; Sohma Y; Li M; Hwang TC
    J Gen Physiol; 2007 Apr; 129(4):285-98. PubMed ID: 17353351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biophysics, biochemistry and physiology of CFTR.
    Moran O
    Cell Mol Life Sci; 2017 Jan; 74(1):1-2. PubMed ID: 27704173
    [No Abstract]   [Full Text] [Related]  

  • 5. The gating of the CFTR channel.
    Moran O
    Cell Mol Life Sci; 2017 Jan; 74(1):85-92. PubMed ID: 27696113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of disease-associated cystic fibrosis transmembrane conductance regulator mutants by hydrolyzable ATP analogs.
    Miki H; Zhou Z; Li M; Hwang TC; Bompadre SG
    J Biol Chem; 2010 Jun; 285(26):19967-75. PubMed ID: 20406820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis transmembrane conductance regulator (CFTR) potentiators protect G551D but not ΔF508 CFTR from thermal instability.
    Liu X; Dawson DC
    Biochemistry; 2014 Sep; 53(35):5613-8. PubMed ID: 25148434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural mechanisms for defective CFTR gating caused by the Q1412X mutation, a severe Class VI pathogenic mutation in cystic fibrosis.
    Yeh JT; Yu YC; Hwang TC
    J Physiol; 2019 Jan; 597(2):543-560. PubMed ID: 30408177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanosensitivity of wild-type and G551D cystic fibrosis transmembrane conductance regulator (CFTR) controls regulatory volume decrease in simple epithelia.
    Xie C; Cao X; Chen X; Wang D; Zhang WK; Sun Y; Hu W; Zhou Z; Wang Y; Huang P
    FASEB J; 2016 Apr; 30(4):1579-89. PubMed ID: 26683699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual activity of aminoarylthiazoles on the trafficking and gating defects of the cystic fibrosis transmembrane conductance regulator chloride channel caused by cystic fibrosis mutations.
    Pedemonte N; Tomati V; Sondo E; Caci E; Millo E; Armirotti A; Damonte G; Zegarra-Moran O; Galietta LJ
    J Biol Chem; 2011 Apr; 286(17):15215-26. PubMed ID: 21383017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation-specific dual potentiators maximize rescue of CFTR gating mutants.
    Veit G; Da Fonte DF; Avramescu RG; Premchandar A; Bagdany M; Xu H; Bensinger D; Stubba D; Schmidt B; Matouk E; Lukacs GL
    J Cyst Fibros; 2020 Mar; 19(2):236-244. PubMed ID: 31678009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation.
    De Boeck K; Munck A; Walker S; Faro A; Hiatt P; Gilmartin G; Higgins M
    J Cyst Fibros; 2014 Dec; 13(6):674-80. PubMed ID: 25266159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rattlesnake Phospholipase A2 Increases CFTR-Chloride Channel Current and Corrects ∆F508CFTR Dysfunction: Impact in Cystic Fibrosis.
    Faure G; Bakouh N; Lourdel S; Odolczyk N; Premchandar A; Servel N; Hatton A; Ostrowski MK; Xu H; Saul FA; Moquereau C; Bitam S; Pranke I; Planelles G; Teulon J; Herrmann H; Roldan A; Zielenkiewicz P; Dadlez M; Lukacs GL; Sermet-Gaudelus I; Ollero M; Corringer PJ; Edelman A
    J Mol Biol; 2016 Jul; 428(14):2898-915. PubMed ID: 27241308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting species differences to understand the CFTR Cl- channel.
    Bose SJ; Scott-Ward TS; Cai Z; Sheppard DN
    Biochem Soc Trans; 2015 Oct; 43(5):975-82. PubMed ID: 26517912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ivacaftor potentiation of multiple CFTR channels with gating mutations.
    Yu H; Burton B; Huang CJ; Worley J; Cao D; Johnson JP; Urrutia A; Joubran J; Seepersaud S; Sussky K; Hoffman BJ; Van Goor F
    J Cyst Fibros; 2012 May; 11(3):237-45. PubMed ID: 22293084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of phenylalanine 508 causes attenuated phosphorylation-dependent activation of CFTR chloride channels.
    Wang F; Zeltwanger S; Hu S; Hwang TC
    J Physiol; 2000 May; 524 Pt 3(Pt 3):637-48. PubMed ID: 10790148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CFTR ion channel: gating, regulation, and anion permeation.
    Hwang TC; Kirk KL
    Cold Spring Harb Perspect Med; 2013 Jan; 3(1):a009498. PubMed ID: 23284076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential sensitivity of the cystic fibrosis (CF)-associated mutants G551D and G1349D to potentiators of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel.
    Cai Z; Taddei A; Sheppard DN
    J Biol Chem; 2006 Jan; 281(4):1970-7. PubMed ID: 16311240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Changes Fundamental to Gating of the Cystic Fibrosis Transmembrane Conductance Regulator Anion Channel Pore.
    Linsdell P
    Adv Exp Med Biol; 2017; 925():13-32. PubMed ID: 27311317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structural basis of cystic fibrosis.
    Meng X; Clews J; Martin ER; Ciuta AD; Ford RC
    Biochem Soc Trans; 2018 Oct; 46(5):1093-1098. PubMed ID: 30154098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.